Triple targeting of ALOX5, COX-2 and double mutant EGFR by novel quinazolinone tethered phenyl urea derivatives demonstrate anti-inflammatory and anti-cancer activities in numerous cancer cell lines, not limited to BT-459 breast cancer cell line [231]. The gene discussed is EGFR; the disease is cancer.